Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Cosmos Health signs LOI to acquire Doc Pharma S.A.
-
HONG KONG, June 11, 2026 (GLOBE NEWSWIRE) -- According to ME, on June 1, 2026, the Central Bank of Bahrain granted the country’s first stablecoin issuer license to AXG, a Nasdaq-listed company. The...
-
Artificial Analysis, the independent AI benchmark organisation, ranks HyperNova 60B as the lowest-parameter model in the "most attractive quadrant" of its intelligence-versus-size comparison, the only...
-
Cosmos Health secures additional 180-day Nasdaq extension to regain compliance.
-
Athlon Family Office Announces Speakers and Sponsors for Upcoming Elite Family Office Sports Summit June 23–24
-
ARRAY Technologies Surpasses 100 GW Milestone, highlighting ARRAY's leadership and expansion to meet growing demand in the utility-scale solar industry.
-
Recognised in the DATs & ETFs category of Fortune's definitive ranking of the companies and protocols shaping the global digital asset ecosystem JERSEY, Channel Islands — June 11, 2026 —...
-
Southlake, TX, June 11, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing...
-
-- Single dose of vispa-cel produced durable responses in 2L LBCL patients: 82% ORR, 67% CR rate, and 17.1-month mPFS -- -- Generally well-tolerated safety profile continues to support outpatient...
-
-- Single dose of CB-011 produced deep, durable responses in heavily pretreated, BCMA-naïve patients with r/r MM: 83% CR rate, 91% MRD negativity, and 50% of patients in ≥CR at 15 months -- -- Case...